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Volume 53, Number 17S Abstracts 103Smost common in CAS than in CEA patients (30.7% vs
26.6%, p0.042). Diabetic patients were younger
(p0.005) and more frequently had hypertension
(p0.015) or coronary disease (p0.019). Perioperative
stroke/death rate was 2.3% (36/1568) in non-diabetic vs
2.7% (17/629) in diabetic patients (p0.54); 3.4% in
diabetic CEA group and 2.1% in diabetic CAS group. At
multivariate analyses diabetes was found predictor of peri-
operative stroke/death only in CEA group (OR 3.04;
95%CI 1.107-8.362; p0.031) but not in CAS group
(p0.45) or in overall patients (p0.38). Six-year survival
was 78.4% in diabetic and 82.5% in non-diabetic (p0.15).
The 6-year risk of late stroke was similar (5.0%) in diabetic
and non diabetic patients. Six-year restenosis estimates
were 5% in diabetic and 8% in non-diabetic patients
(p0.1). Survival, late stroke and restenosis rates between
diabetic and non-diabetic were similar in CAS and CEA
groups.
Conclusions: Diabetic patients are not at greater risk
of perioperative morbidity, mortality and late stroke after
CAS.
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Objectives: Venous thromboembolic disease (VTE) is
a major cause of morbidity and mortality in hospitalized
patients. Despite evidence confirming the benefit of pro-
phylaxis, many patients do not receive prevention and
develop VTE.We implemented and studied a hospital wide
program to assure all patients have VTE risk and prevention
addressed.
Methods: Beginning June 2010, all patients admitted
to a 2,300 bed academic medical center had VTE risk
addressed in their electronic admission orders. Risk assess-
ment and prophylaxis were monitored using Microsoft
AMALGA software and hospital electronic health record
(ECLIPSYS). VTE rates were monitored through chart
review by certified coders. Rates were calculated as VTE per
1000 patient discharges and rates were compared with
chi-square. AMALGA software allowed real-time assess-
ment of all patients risk scores and prophylaxis regimens. Ghe number of discharges from the institution is approxi-
ately 62,000 per year.
Results: Data are shown in table 1. Compared to the
rst half of 2010 VTE decreased significantly after im-
lementation of the program. Compliance with prophy-
axis also doubled after implementation. 32% of patients
eemed low-risk by admitting physician were actually
igh risk. Of these, 65% were already on appropriate
rophylaxis. In the remaining 35%, responsible physi-
ians were contacted and prophylaxis implemented un-
ess contraindicated.
Conclusions: A hospital-wide VTE prevention pro-
ram that evaluates all admitted patients is feasible even in
arge medical centers. Preliminary data suggest that there is
significant decrease in VTE events and significant im-
rovement in prophylaxis rates. The AMALGA software
llows real-time monitoring of risk and prophylaxis result-
ng in the ability to correct errors and provide appropriate
rophylaxis when indicated.
Innappropriate
prophylaxis
Rate of VTE per
1000 discharges
re implementation 46% 5.75
ost implementation 22% 4.22
p.011 p .003
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Objectives: Post-thrombotic syndrome (PTS) is a
ommon chronic complication of acute deep venous
hrombosis (DVT) in the lower extremity with as many as
wo-thirds of patients developing symptoms of pain,
dema, hyperpigmentation or ulceration. The role of grad-
ated compressive stockings (30-40mmHg knee length) in
he prevention of PTS has been studied with the opinion
eing divided on the beneficial effects. We aim to answer
his question with a randomized controlled study that used
ultiple scoring instruments to assess post thrombotic
yndrome.
Methods: 69 consecutive patients with an acute
VT diagnosed by duplex ultrasonography were ran-
omized to treatment with graduated compressive
tockings (GCS) or no stockings to assess the impact of
CS on the prevention of PTS. Venous Clinical Severity
